Decreased hypoxia-inducible factor-1α in gastrocnemius muscle in rats with chronic kidney disease

Kidney and Blood Pressure Research

Volumn 35, Issue 6, 2013, Pages 608-618

  Flisiński, Mariusz ^a   Brymora, Andrzej ^a   Bartłomiejczyk, Irena ^b   Wiśniewska, Ewa ^a   Gołda, Ryszard ^c   Stefańska, Anna ^a   Pa̧czek, Leszek ^b   Manitius, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c KAZIMIERZ WIELKI UNIVERSITY   (Poland)

Author keywords

Chronic kidney disease; Hypoxia inducible factor 1 ; Locomotor muscles; Rats

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINEPHRECTOMY; WESTERN BLOTTING;

ANIMALS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER;

EID: 84865589582     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000339706     Document Type: Article

References (45)

1. Johansen KL, Doyle J, Sakkas GK, Kent-Braun JA: Neural and metabolic mechanisms of excessive muscle fatigue in maintenance hemodialysis patients. Am J Physiol Regul Integr Comp Physiol 2005; 289:R805-R813.
2. Lombard JH, Frisbee JC, Greene AS, Hudetz AG, Roman RJ, Tonellato PJ: Microvascular flow and tissue PO(2) in skeletal muscle of chronic reduced renal mass hypertensive rats. Am J Physiol Heart Circ Physiol 2000; 279:H2295-H2302.
3. Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, Song Y, Min H, Wang X, Du J, Mitch WE: Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 2011; 25: 1653-1663.
4. Marrades RM, Roca J, Campistol JM, Diaz O, Barberá JA, Torregrosa JV, Masclans JR, Cobos A, Rodríguez-Roisin R, Wagner PD: Effects of erythropoietin on muscle O 2 transport during exercise in patients with chronic renal failure. J Clin Invest 1996; 97: 2092-2100.
5. Sala E, Novszewski EA, Campistol JM: Impaired muscle oxygen transfer in patients with chronic renal failure. Am J Physiol 2001; 280:R1240-R1248.
6. Flisiński M, Brymora A, Elminowska-Wenda G, Bogucka J, Walasik K, Stefańska A, Odrowaz-Sypniewska G, Manitius J: Influence of different stages of experimental chronic kidney disease on rats locomotor and postural skeletal muscles microcirculation. Ren Fail 2008; 30: 443-451.
7. Marrades RM, Alonso J, Roca J, González de Suso JM, Campistol JM, Barberá JA, Diaz O, Torregrosa JV, Masclans JR, Rodríguez-Roisin R, Wagner PD: Cellular bioenergetics after erythropoietin therapy in chronic renal failure. J Clin Invest 1996; 97: 2101-2110.
8. Semenza GL: HIF-1, O(2), and the 3 PHDs: How animal cells signal hypoxia to the nucleus. Cell 2001; 107: 1-3.
9. Nangaku M: Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
10. Huang LE, Gu J, Schau M, Bunn HF: Regulation of hypoxia-inducible factor 1alpha is mediated by an O 2 -dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95: 7987-7992.
11. Mounier R, Pedersen BK, Plomgaard P: Muscle-specific expression of hypoxia-inducible factor in human skeletal muscle. Exp Physiol 2010; 95: 899-907.
12. Pisani DF, Dechesne CA: Skeletal muscle HIF-1alpha expression is dependent on muscle fiber type. J Gen Physiol 2005; 126: 173-178.
13. Yoon D, Pastore YD, Divoky V, Liu E, Mlodnicka AE, Rainey K, Ponka P, Semenza GL, Schumacher A, Prchal JT: HIF-1 - deficiency results in dysregulated EPO signaling and iron homeostasis in mouse development. J Biol Chem 2006; 281: 25703-25711.
14. Hagström L, Agbulut O, El-Hasnaoui-Saadani R, Marchant D, Favret F, Richalet JP, Beaudry M, Launay T: Epo is relevant neither for microvascular formation nor for the new formation and maintenance of mice skeletal muscle fibres in both normoxia and hypoxia. J Biomed Biotechnol 2010; 2010: 137817.
15. Ameln H, Gustafsson T, Sundberg CJ, Okamoto K, Jansson E, Poellinger L, Makino Y: Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J 2005; 19: 1009-1011.
16. Vogt M, Puntschart A, Geiser J, Zuleger C, Billeter R, Hoppeler H: Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions. J Appl Physiol 2001; 91: 173-182.
17. Munch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, Niwa T, Lemke HD, Schinzel R: Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997; 35: 669-677.
18. User Bulletin 2 Y ABI PRISM 7700 Sequence Detection System. Foster City, Applied Biosystems, 1997 (updated 10/2001).
19. Drewa T, Joachimiak R, Kaznica A, Flisinski M, Brymora A, Manitius J: Bone marrow progenitors from animals with chronic renal failure lack capacity of in vitro proliferation. Transplant Proc 2008; 40: 1668-1673.
20. Natarajan R, Fisher BJ, Fowler AA 3rd: Regulation of hypoxia inducible factor-1 by nitric oxide in contrast to hypoxia in microvascular endothelium. FEBS Lett 2003; 549: 99-104.
21. Booth FW, Baldwin KM: Muscle plasticity: Energy demand and supply processes; in: Handbook of Physiology: Integration of Motor, Circulatory, Respiratory, and Metabolic Control during Exercise. Bethesda, American Physiological Society, 1996, pp 1075-1123.
22. Anderson EJ, Neufer PD: Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am J Physiol Cell Physiol 2006; 290:C844-C851.
23. Pialoux V, Mounier R, Brown AD, Steinback CD, Rawling JM, Poulin MJ: Relationship between oxidative stress and HIF-1 - mRNA during sustained hypoxia in humans. Free Radic Biol Med 2009; 46: 321-326.
24. Yu Z, Li P, Zhang M, Hannink M, Stamler JS, Yan Z: Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli. PLoS One 2008; 3:e2086.
25. Palmer LA, Semenza GL, Stoler MH, Johns RA: Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol Lung Cell Mol Physiol 1998; 274:L212-L219.
26. Vaux EC, Metzen E, Yeates KM, Ratcliffe PJ: Regulation of hypoxia inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood 2001; 98: 296-302.
27. Sandau KB, Fandrey J, Brüne B: Accumulation of HIF-1alpha under the influence of nitric oxide. Blood 2001; 97: 1009-1015.
28. Hagen T, Taylor CT, Lam F, Moncada S: Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIF1alpha. Science 2003; 302: 1975-1978.
29. Wellman TL, Jenkins J, Penar PL, Tranmer B, Zahr R, Lounsbury KM: Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries. FASEB J 2004; 18: 379-381.
30. Köhl R, Zhou J, Brüne B: Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1alpha stabilization. Free Radic Biol Med 2006; 40: 1430-1442
31. Thomas DD, Ridnour LA, Espey MG, Donzelli S, Ambs S, Hussain SP, Harris CC, De-Graff W, Roberts DD, Mitchell JB, Wink DA: Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem 2006; 281: 25984-25993.
32. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC: HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3: 187-197.
33. Brüne B, Zhou J: Nitric oxide and superoxide: Interference with hypoxic signaling. Cardiovasc Res 2007; 75: 275-282.
34. Shah AJ, Sahgal V, Quintanilla AP, Subramani V, Singh H, Hughes R: Muscle in chronic uremia Y a histochemical and morphometric study of human quadriceps muscle biopsy. Clin Neuropathol 1983; 2: 83-89.
35. Mason SD, Howlett RA, Kim MJ, Olfert IM, Hogan MC, McNulty W, Hickey RP, Wagner PD, Kahn CR, Giordano FJ, Johnson RS: Loss of skeletal muscle HIF-1 - results in altered exercise endurance. PLoS Biol 2004; 2:e288.
36. Kopple JD, Wang H, Fournier M, Storer T, Zhang SM, Song HY, Lewis M: Transcriptional levels of growth factors in skeletal muscle of maintenance hemodialysis patients. J Ren Nutr 2006; 16: 212-215.
37. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538.
38. Lim PS, Cheng YM, Wei YH: Large-scale mitochondrial DNA deletions in skeletal muscle of patients with end-stage renal disease. Free Radic Biol Med 2000; 29: 454-463.
39. Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML, Vacca M, D'Esposito M, D'Urso M, Galletti P, Zappia V: Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003; 361: 1693-1699.
40. Dery MA, Michaud MD, Richard DE: Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005; 37: 535-540.
41. Pajusola K, Künnapuu J, Vuorikoski S, Soronen J, André H, Pereira T, Korpisalo P, Ylä-Herttuala S, Poellinger L, Alitalo K: Stabilized HIF-1 - is superior to VEGF for angiogenesis in skeletal muscle via adenoassociated virus gene transfer. FASEB J 2005; 19: 1365-1367.
42. Jacobi J, Porst M, Cordasic N, Namer B, Schmieder RE, Eckardt KU, Hilgers KF: Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb reperfusion in rats. Kidney Int 2006; 69: 2013-2021.
43. Bagi Z, Hamar P, Antus B, Rosivall L, Koller A: Chronic renal failure leads to reduced flow-dependent dilatation in isolated rat skeletal muscle arterioles due to lack of NO mediation. Kidney Blood Press Res 2003; 26: 19-26.
44. Milkiewicz M, Doyle JL, Fudalewski T, Ispanovic E, Aghasi M, Haas TL: HIF-1alpha and HIF-2alpha play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle. J Physiol 2007; 583: 753-766.
45. Bernhardt WM, Wiesener MS, Scigalla P, Chou J, Schmieder RE, Günzler V, Eckardt KU: Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol 2010; 21: 2151-2156.